Surveillance (samples tested for ASF) in whole country during reporting period**	Passive surveillance in WB*			Passive surveillance in DP*
	Diagnostic test(s) used	Total samples	Positive samples	Diagnostic test(s) used	Total samples	Positive samples
	PCR	12	0	PCR	13	0
	ELISA	0	NA	ELISA	0	NA
	Active surveillance in WB*			Active surveillance in WB*
	Diagnostic test(s) used	Total samples	Positive samples	Diagnostic test(s) used	Total samples	Positive samples
	PCR	31	0	PCR	15	0
	ELISA	0	NA	ELISA	626	0
	ELISA + IPT	NA	NA	ELISA + IPT	NA	NA
	ELISA + IB	NA	NA	ELISA + IB	NA	NA
Surveillance in NUTS 3 areas with at least one ASF notification during the reporting period**	Passive surveillance in WB*			Passive surveillance in DP*
	Diagnostic test(s) used	Total samples	Positive samples	Diagnostic test(s) used	Total samples	Positive samples
	PCR	NA	NA	PCR	NA	NA
	ELISA	NA	NA	ELISA	NA	NA
	Active surveillance in WB*			Active surveillance in WB*
	Diagnostic test(s) used	Total samples	Positive samples	Diagnostic test(s) used	Total samples	Positive samples
	PCR	NA	NA	PCR	NA	NA
	ELISA	NA	NA	ELISA	NA	NA

ND: no data provided to EFSA; NA: Not applicable.

*: See Section 3.1.1 for definitions.

**: Sample data, as described in Section 2.2 were not submitted to EFSA’s Data Collection Framework, but aggregated data have been provided directly by the Greek WG member to complete this table.